Enhanced enzymatic degradation of tryptophan by indoleamine 2,3-dioxygenase contributes to the tryptophan-deficient state seen after major trauma

Shock

Volumn 23, Issue 3, 2005, Pages 209-215

  Pellegrin, Katharina ^a,e   Neurauter, Gabriele ^d   Wirleitner, Barbara ^c   Fleming, Arthur W ^a   Peterson, Verlyn M ^b   Fuchs, Dietmar ^d  

^a KING DREW MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF INNSBRUCK   (Austria)

^d LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^e Hand/Microvascular and Gen Surgery   (United States)

Author keywords

ARDS; Clinical study; Cytokines; IDO; IFN ; Lymphopenia; Sepsis

Indexed keywords

GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINE; TRYPTOPHAN;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; ENZYMATIC DEGRADATION; FEMALE; HUMAN; IMMUNE DEFICIENCY; INJURY; LYMPHOCYTE PROLIFERATION; LYMPHOCYTOPENIA; MALE; MULTIPLE ORGAN FAILURE; OPPORTUNISTIC INFECTION; SEPSIS;

ADOLESCENT; ADULT; BACTEREMIA; CASE-CONTROL STUDIES; CHILD; FEMALE; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON TYPE II; KYNURENINE; LYMPHOPENIA; MALE; MULTIPLE ORGAN FAILURE; PROGNOSIS; PROSPECTIVE STUDIES; RESPIRATORY DISTRESS SYNDROME, ADULT; SEPSIS; TRYPTOPHAN; TRYPTOPHAN OXYGENASE; WOUNDS AND INJURIES;

EID: 14344251865     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000150773.16613.d3     Document Type: Article

References (34)

1. Napolitano LM, Faist E, Wichmann MW, Coimbra R: Immune dysfunction in trauma. Surg Clin North Am 79:1385-1416, 1999.
2. Bone RC: Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann Intern Med 125:680-687, 1996.
3. Mayoral JL, Schweich CJ, Dunn DL: Decreased tumor necrosis factor production during the initial stages of infection correlates with survival during murine gram-negative sepsis. Arch Surg 125:24-27, discussion 28, 1990.
4. Echtenacher B, Falk W, Mannel DN, Krammer PH: Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. J Immunol 145:3762-3766, 1990.
5. Billiau A, Matthys P: Interferon-gamma, more of a cachectin than tumor necrosis factor. Cytokine 4:259-263, 1992.
6. Hensler T, Heinemann B, Sauerland S, Lefering R, Bouillon B, Andermahr J, Neugebauer EA: Immunologic alterations associated with high blood transfusion volume after multiple injury: effects on plasmatic cytokine and cytokine receptor concentrations. Shock 20:497-502, 2003.
7. Toliver-Kinsky TE, Varma TK, Lin CY, Herndon DN, Sherwood ER: Interferon-gamma production is suppressed in thermally injured mice: decreased production of regulatory cytokines and corresponding receptors. Shock 18:322-330, 2002.
8. Murphey ED, Lin CY, McGuire RW, Toliver-Kinsky T, Herndon DN, Sherwood ER: Diminished bacterial clearance is associated with decreased IL-12 and interferon-gamma production but a sustained proinflammatory response in a murine model of postseptic immunosuppression. Shock 21:415-425, 2004.
9. Robin F: Koller, Wachter course of immune activation markers in patients after severe multiple trauma. Pteridines 2:95-97, 1990.
10. Werner ER, Bitterlich G, Fuchs D, Hausen A, Reibnegger G, Szabo G, Dierich MP, Wachter H: Human macrophages degrade tryptophan upon induction by interferon-gamma. Life Sci 41:273-280, 1987.
11. Taylor MW, Feng GS: Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J 5:2516-2522, 1991.
12. Munn DH, Shafizadeh E, Attwood JT, Bondarev I, Pashine A, Mellor AL: Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med 189:1363-1372, 1999.
13. Hwu P, Du MX, Lapointe R, Do M, Taylor MW, Young HA: Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J Immunol 164:3596-3599, 2000.
14. Mellor AL, Munn DH: Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation? Immunol Today 20:469-473, 1999.
15. Faist E: The mechanisms of host defense dysfunction following shock and trauma. Curr Top Microbiol Immunol 216:259-274, 1996.
16. Campos AC, Meguid MM: A critical appraisal of the usefulness of perioperative nutritional support. Am J Clin Nutr 55:117-130, 1992.
17. Denz H, Orth B, Weiss G, Herrmann R, Huber P, Wachter H, Fuchs D: Weight loss in patients with hematological neoplasias is associated with immune system stimulation. Clin Investig 71:37-41, 1993.
18. Fuchs D. Moller AA, Reibnegger G, Stockle E, Werner ER, Wachter H: Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/psychiatric symptoms. J Acquir Immune Defic Syndr 3:873-876, 1990.
19. Gajewski TF, Fitch FW: Anti-proliferative effect of IFN-gamma in immune regulation. IV. Murine CTL clones produce IL-3 and GM-CSF, the activity of which is masked by the inhibitory action of secreted IFN-gamma. J Immunol 144:548-556, 1990.
20. Widner B, Sepp N, Kowald E, Ortner U, Wirleitner B, Fritsch P, Baier-Bitterlich G, Fuchs D: Enhanced tryptophan degradation in systemic lupus erythematosus. Immunobiology 201:621-630, 2000.
21. Giusti RM, Maloney EM, Hanchard B, Morgan OS, Steinberg SM, Wachter H, Williams E, Cranston B, Fuchs D, Manns A: Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis, and adult T-cell leukemia/lymphoma. Cancer Epidemiol Biomarkers Prev 5:699-704, 1996.
22. Heyes MP, Saito K, Crowley JS, Davis LE, Demitrack MA, Der M, Dilling LA, Elia J, Kruesi MJP, Lackner A, Larsen SA, Lee K, Leonard HL, Markey SP, Martin A, Milstein S, Mouradian MM, Pranzatelli MR, Quearry BJ, Salazar A, Smith M, Strauss SE, Sunderland T, Swedo SW, Tourtellotte WW: Quinolinic acid and kynurenine pathway metabolism in inflammatory and noninflammatory neurological disease. Brain 115:1249-1273, 1992.
23. Bone RC, Sibbald WJ, Sprung CL: The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 101:1481-1483, 1992.
24. Widner B, Werner ER, Schennach H, Wachter H, Fuchs D: Simultaneous measurement of serum tryptophan and kynurenine by HPLC. Clin Chem 43:2424-2426, 1997.
25. Moore FA, Moore EE, Jones TN, McCroskey BL, Peterson VM: TEN versus TPN following major abdominal trauma - reduced septic morbidity. J Trauma 29:916-922, discussion 922-923, 1989.
26. Moore FA, Moore EE, Poggetti R, McAnena OJ, Peterson VM, Abernathy CM, Parsons PE: Gut bacterial translocation via the portal vein: a clinical perspective with major torso trauma. J Trauma 31:629-636, discussion 636-638, 1991.
27. Meisel R, Zibert A, Laryea M, Gobel U, Daubener W, Dilloo D: Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 103:4619-4621, 2004.
28. Selleri C, Maciejewski JP, Sato T, Young NS: Interferon-gamma constitutively expressed in the stromal microenvironment of human marrow cultures mediates potent hematopoietic inhibition. Blood 87:4149-4157, 1996.
29. Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, Marshall B, Brown C, Mellor AL: Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281:1191-1193, 1998.
30. Durant R, Klouche K, Delbosc S, Morena M, Amigues L, Beraud JJ, Canaud B, Cristol JP: Superoxide anion overproduction in sepsis: effects of vitamin e and simvastatin. Shock 22:34-39, 2004.
31. Wagner C, Kaksa A, Muller W, Denefleh B, Heppert V, Wentzensen A, Hansch GM: Polymorphonuclear neutrophils in posttraumatic osteomyelitis: cells recovered from the inflamed site lack chemotactic activity but generate Superoxides. Shock 22:108-115, 2004.
32. Knoferl MW, Liener UC, Perl M, Bruckner UB, Kinzl L, Gebhard F: Blunt chest trauma induces delayed splenic immunosuppression. Shock 22:51-56, 2004.
33. Papadaki HA, Eliopoulos AG, Kosteas T, Gemetzi C, Damianaki A, Koutala H, Bux J, Eliopoulos GD: Impaired granulocytopoiesis in patients with chronic idiopathic neutropenia is associated with increased apoptosis of bone marrow myeloid progenitor cells. Blood 101:2591-2600, 2003.
34. Peterson VM, Murphy JR, Haddix T, Ford P, Anderson SJ, Bartle EJ: Identification of novel prognostic indicators in burned patients. J Trauma 28:632-637, 1988.